Plasma levels of resistin-like molecule beta in humans

Cancer Epidemiology

Volumn 35, Issue 5, 2011, Pages 485-489

  Neilson, Andrew P ^a,b   Djuric, Zora ^a,b   Land, Susan ^c   Kato, Ikuko ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Physical activity; Resistin; Resistin like molecule beta; Smoking

Indexed keywords

CALCIUM; NONSTEROID ANTIINFLAMMATORY AGENT; RESISTIN; RESISTIN LIKE MOLECULE BETA; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; BODY HEIGHT; BODY MASS; CALCIUM INTAKE; CALORIC INTAKE; CANCER RISK; CAUCASIAN; COLON POLYP; COLORECTAL CANCER; DIETARY FIBER; DRUG USE; EDUCATIONAL STATUS; FEMALE; HISPANIC; HUMAN; LIFESTYLE; MALE; MEDICAL HISTORY; NORMAL HUMAN; OBESITY; PHYSICAL ACTIVITY; PILOT STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RECTUM POLYP; RED MEAT; SMOKING;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OBESITY; PILOT PROJECTS; PROGNOSIS; RECTUM; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052937506     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2010.10.007     Document Type: Article

References (50)

1. Steppan C.M., Brown E.J., Wright C.M., Bhat S., Banerjee R.R., Dai C.Y., et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001, 98:502-506.
2. Shojima N., Ogihara T., Inukai K., Fujishiro M., Sakoda H., Kushiyama A., et al. Serum concentrations of resistin-like molecules beta and gamma are elevated in high-fat-fed and obese db/db mice, with increased production in the intestinal tract and bone marrow. Diabetologia 2005, 48:984-992.
3. Rajala M.W., Obici S., Scherer P.E., Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 2003, 111:225-230.
4. Kushiyama A., Shojima N., Ogihara T., Inukai K., Sakoda H., Fujishiro M., et al. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J Biol Chem 2005, 280:42016-42025.
5. Barnes S.L., Vidrich A., Wang M.L., Wu G.D., Cominelli F., Rivera-Nieves J., et al. Resistin-like molecule beta (RELM beta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis. J Immunol 2007, 179:7012-7020.
6. Hogan S.P., Seidu L., Blanchard C., Groschwitz K., Mishra A., Karow M.L., et al. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Aller Clin Immunol 2006, 118:257-268.
7. Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., Keilbaugh S.A., Hamady M., Chen Y.Y., et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137:1716-1724.
8. He W.M., Wang M.L., Jiang H.Q., Steppan C.M., Shin M.E., Thurnheer M.C., et al. Bacterial colonization leads to the colonic secretion of RELM beta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology 2003, 125:1388-1397.
9. Fujio J., Kushiyama A., Sakoda H., Fujishiro M., Ogihara T., Fukushima Y., et al. Regulation of gut-derived resistin-like molecule beta expression by nutrients. Diabetes Res Clin Pract 2008, 79:2-10.
10. Asano T., Sakosda H., Fujishiro M., Anai M., Kushiyama A., Horike N., et al. Physiological significance of resistin and resistin-like molecules in the inflammatory process and insulin resistance. Curr Diabetes Rev 2006, 2:449-454.
11. Zheng L.D., Tong Q.S., Weng M.X., He J., Lv Q., Pu J.R., et al. Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance. Dig Dis Sci 2009, 54:274-281.
12. Zheng L.D., Weng M.X., He J., Yang X.P., Jiang G.S., Tong Q.S. Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis. Virch Archiv 2010, 456:53-63.
13. Zheng L.D., Tong Q.S., Weng M.X., He J., Lv Q., Wu Z.H., et al. Expression of resistin-like molecule beta in Barrett's esophagus: a novel biomarker for metaplastic epithelium. Dig Dis Sci 2010, 55:32-39.
14. De Young M.P., Damania H., Scheurle D., Zylberberg C., Narayanan R. Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer. In Vivo 2002, 16:239-248.
15. Aparna R., Christiane H., Frank R., Walter K., Friedrich G., Werner S., et al. Human RELMβ is a mitogenic factor in lung cells and induced in hypoxia. FEBS Lett 2006, 580:900-903.
16. Kato I., Land S., Majumdar A.P., Barnholtz-Sloan J., Severson R.K. Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer. Cancer Epidemiol 2010, 34:291-297.
17. Block G., Thompson F.E., Hartman A.M., Larkin F.A., Guire K.E. Comparison of 2 dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992, 92:686-693.
18. Block G., Woods M., Potosky A., Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990, 43:1327-1335.
19. Kato I., Nomura A., Stemmermann G.N., Chyou P.H. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors. Dig Dis Sci 1992, 37:784-790.
20. Tsukahara T., Nakashima E., Watarai A., Hamada Y., Naruse K., Kamiya H., et al. Polymorphism in resistin promoter region at-420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2009, 84:179-186.
21. Wang J., Wang S.H., Shang L.X., Dong X., Wang X., Zhang F., et al. Relationship of adiponectin and resistin levels in umbilical and maternal serum with fetal macrosomia. J Obstet Gynaecol Res 2010, 36:533-537.
22. Haluzikova D., Dostalova I., Kavalkova P., Roubicek T., Mraz M., Papezova H., et al. Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 2009, 58:577-581.
23. Dimitriadis K., Tsioufis C., Selima M., Tsiachris D., Miliou A., Kasiakogias A., et al. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J Hum Hypertens 2009, 23:668-673.
24. Kuzmicki M., Telejko B., Szamatowicz J., Zonenberg A., Nikolajuk A., Kretowski A., et al. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009, 25:258-263.
25. Qasim A.N., Metkus T.S., Tadesse M., Lehrke M., Restine S., Wolfe M.L., et al. Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians. Clin Endocrinol 2009, 70:698-705.
26. Iglesias P., Fidalgo P.A., Codoceo R., Diez J.J. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol 2003, 59:621-629.
27. Phoenix Pharmaceuticals, Inc. RELM-beta (Mouse) RIA Kit Data Sheet. Accessed on December, 2009. http://www.%20phoenixbiotech.net/qcdata/RIK/QCK2832.html.
28. Ii H., Yokoyama N., Yoshida S., Tsutsumi K., Hatakeyama S., Sato T., et al. Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice. PLoS One 2009, 4:e8089.
29. Damsgaard C.T., Lauritzen L., Calder P.C., Kjaer T.M.R., Frokiaer H. Whole-blood culture is a valid low-cost method to measure monocytic cytokines - a comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytes. J Immunol Methods 2009, 340:95-101.
30. Boenisch O., Ehmke K.D., Heddergott A., Naoum C., Frei U., Schindler R. C-reactive-protein and cytokine plasma levels in hemodialysis patients. J Nephrol 2002, 15:547-551.
31. Lee S.A., Kallianpur A., Xiang Y.B., Wen W.Q., Cai Q.Y., Liu D., et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 2007, 16:2464-2470.
32. Munitz A., Seidu L., Cole E.T., Ahrens R., Hogan S.P., Rothenberg M.E., Resistin-Like Molecule alpha decreases glucose tolerance during intestinal inflammation. J Immunol 2009, 182:2357-2363.
33. Rennie K.L., Coward A., Jebb S.A. Estimating under-reporting of energy intake in dietary surveys using an individualised method. Br J Nutr 2007, 97:1169-1176.
34. Lichtman S.W., Pisarska K., Berman E.R., Pestone M., Dowling H., Offenbacher E., et al. Discrepancy between self-reported and actual caloric-intake and exercise in obese subjects. N Engl J Med 1992, 327:1893-1898.
35. Ferrari P., Friedenreich C., Matthews C.E. The role of measurement error in estimating levels of physical activity. Am J Epidemiol 2007, 166:832-840.
36. Olafsdottir A.S., Thorsdottir I., Gunnarsdottir I., Thorgeirsdottir H., Steingrimsdottir L. Comparison of women's diet assessed by FFQs and 24-hour recalls with and without underreporters: Associations with biomarkers. Ann Nutr Metab 2006, 50:450-460.
37. Hill D.A., Hoffmann C., Abt M.C., Du Y., Kobuley D., Kirn T.J., et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 2009, 3:148-158.
38. Nerstedt A., Nilsson E.C., Ohlson K., Hakansson J., Svensson L.T., Lowenadler B., et al. Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. Br J Nutr 2007, 97:1117-1127.
39. Davis C.D., Milner J.A. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 2009, 20:743-752.
40. Kato I., Nechvatal J.M., Dzinic S., Basson M.D., Majumdar A.P., Ram J.L. Smoking and other personal characteristics as potential predictors for fecal bacteria populations in humans. Med Sci Monitor 2010, 16:CR1-CR7.
41. Woodmansey E.J. Intestinal bacteria and ageing. J Appl Microbiol 2007, 102:1178-1186.
42. Vannucci L., Stepankova R., Grobarova V., Kozakova H., Rossmann P., Klimesova K., et al. Colorectal carcinoma: Importance of colonic environment for anti-cancer response and systemic immunity. J Immunotoxicol 2009, 6:217-226.
43. Sieverdes J.C., Sui X.M., Lee D.C., Church T.S., McClain A., Hand G.A., et al. Physical activity, cardiorespiratory fitness and the incidence of type 2 diabetes in a prospective study of men. Br J Sport Med 2010, 44:238-244.
44. Myint P.K., Luben R.N., Wareham N.J., Bingham S.A., Khaw K.T. Combined effect of health behaviours and risk of first ever stroke in 20 040 men and women over 11 years' follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): prospective population study. BMJ 2009, 338.
45. Kenchaiah S., Sesso H.D., Gaziano J.M. Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation 2009, 119:44-52.
46. Slattery M.L. Physical activity and colorectal cancer. Sports Med 2004, 34:239-252.
47. Pande M., Lynch P.M., Hopper J.L., Jenkins M.A., Gallinger S., Haile R.W., et al. Smoking and colorectal cancer in lynch syndrome: results from the colon cancer family registry and The University of Texas MD Anderson Cancer Center. Clinl Cancer Res 2010, 16:1331-1339.
48. Poynter J.N., Haile R.W., Siegmund K.D., Campbell P.T., Figueiredo J.C., Limburg P., et al. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev 2009, 18:2745-2750.
49. Wei E.K., Colditz G.A., Giovannucci E.L., Fuchs C.S., Rosner B.A. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the nurses' health study. Am J Epidemiol 2009, 170:863-872.
50. Moxon D., Raza M., Kenney R., Ewing R., Arozullah A., Mason J.B., et al. Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population. Clin Gastroenterol Hepatol 2005, 3:271-278.